216371-66-3Relevant articles and documents
Thapsigargin analogues for targeting programmed death of androgen-independent prostate cancer cells
Brogger Christensen,Andersen, Annette,Kromann, Hasse,Treiman, Marek,Tombal, Bertrand,Denmeade, Sam,Isaacs, John T.
, p. 1273 - 1280 (1999)
A number of analogues of thapsigargin, a selective inhibitor of the sarco-endoplasmic reticulum Ca2+-ATPases have been synthesized. In all of the prepared analogues the butanoyl residue at O-8 has been replaced with a residue containing an arom